ValiRx Balance Sheet Health
Financial Health criteria checks 4/6
ValiRx has a total shareholder equity of £2.9M and total debt of £22.1K, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are £3.1M and £226.5K respectively.
Key information
0.8%
Debt to equity ratio
UK£22.07k
Debt
Interest coverage ratio | n/a |
Cash | UK£174.68k |
Equity | UK£2.90m |
Total liabilities | UK£226.51k |
Total assets | UK£3.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EAJF's short term assets (£566.5K) exceed its short term liabilities (£214.7K).
Long Term Liabilities: EAJF's short term assets (£566.5K) exceed its long term liabilities (£11.9K).
Debt to Equity History and Analysis
Debt Level: EAJF has more cash than its total debt.
Reducing Debt: EAJF's debt to equity ratio has reduced from 10.3% to 0.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EAJF has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EAJF has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.8% each year.